AI assistant
Sending…
Salarius Pharmaceuticals, Inc. — Director's Dealing 2021
Aug 11, 2021
35494_dirs_2021-08-11_61e7884d-a27b-467e-9cbc-6c5d951f6755.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Salarius Pharmaceuticals, Inc. (SLRX)
CIK: 0001615219
Period of Report: 2021-08-10
Reporting Person: HANISH ARNOLD C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-10 | Common Stock | P | 7000 | $0.881 | Acquired | 18350 | Indirect |
More from Salarius Pharmaceuticals, Inc.
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Jan 9
Regulatory Filings
2026
Jan 8
Regulatory Filings
2026
Jan 2
Director's Dealing
2026
Jan 2